Christopher D. McFarland
Affiliations: | 2004-2008 | Physics | University of Rochester, Rochester, NY |
| 2008-2014 | Biophysics | Harvard University, Cambridge, MA, United States | |
| 2014-2018 | Biology | Stanford University, Palo Alto, CA |
Google:
"Christopher McFarland"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Randall H. Morse | research assistant | 2002-2004 | Wadsworth Center/ New York State Dept. of Health (Cell Biology Tree) | |
| Mark E. Dumont | research assistant | 2005-2008 | Rochester | |
| James M. Hogle | grad student | 2014 | Harvard | |
| (The role of deleterious passengers in cancer.) | ||||
| Leonid A. Mirny | grad student | 2008-2014 | MIT and Harvard | |
| (The role of deleterious passengers in cancer) | ||||
| Dmitri Petrov | post-doc | 2014-2018 | Stanford (FlyTree) | |
| Monte M. Winslow | post-doc | 2014-2018 | Stanford (Neurotree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tilk S, Tkachenko S, Curtis C, et al. (2022) Most cancers carry a substantial deleterious load due to Hill-Robertson interference. Elife. 11 |
| Li C, Lin WY, Rizvi H, et al. (2021) Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma. Cancer Research |
| Cai H, Chew SK, Li C, et al. (2021) A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer. Cancer Discovery |
| Cai H, Li C, Chew SK, et al. (2020) Abstract IA26: Multiplexed functional cancer genomics Cancer Research. 80 |
| Rogers ZN, McFarland CD, Winters IP, et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nature Genetics |
| Winters IP, Rogers ZN, McFarland CD, et al. (2018) Abstract IA03: Functional lung cancer genomics through in vivo genome editing Clinical Cancer Research. 24 |
| Winters IP, Chiou SH, Paulk NK, et al. (2017) Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nature Communications. 8: 2053 |
| McFarland C, Yaglom JA, Wojtkowiak JW, et al. (2017) The damaging effect of passenger mutations on cancer progression. Cancer Research |
| Rogers ZN, McFarland CD, Winters IP, et al. (2017) A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nature Methods |
| Grüner BM, Schulze CJ, Yang D, et al. (2016) An in vivo multiplexed small-molecule screening platform. Nature Methods |